326 related articles for article (PubMed ID: 29502160)
1. Evaluation of laser therapy and alpha-lipoic acid for the treatment of burning mouth syndrome: a randomized clinical trial.
Barbosa NG; Gonzaga AKG; de Sena Fernandes LL; da Fonseca AG; Queiroz SIML; Lemos TMAM; da Silveira ÉJD; de Medeiros AMC
Lasers Med Sci; 2018 Aug; 33(6):1255-1262. PubMed ID: 29502160
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory cytokine levels in saliva in patients with burning mouth syndrome before and after treatment with low-level laser therapy.
Pezelj-Ribarić S; Kqiku L; Brumini G; Urek MM; Antonić R; Kuiš D; Glažar I; Städtler P
Lasers Med Sci; 2013 Jan; 28(1):297-301. PubMed ID: 22773117
[TBL] [Abstract][Full Text] [Related]
3. Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial.
Cavalcanti DR; da Silveira FR
J Oral Pathol Med; 2009 Mar; 38(3):254-61. PubMed ID: 19175713
[TBL] [Abstract][Full Text] [Related]
4. A randomized pilot study to assess the safety and the value of low-level laser therapy versus clonazepam in patients with burning mouth syndrome.
Arduino PG; Cafaro A; Garrone M; Gambino A; Cabras M; Romagnoli E; Broccoletti R
Lasers Med Sci; 2016 May; 31(4):811-6. PubMed ID: 26873501
[TBL] [Abstract][Full Text] [Related]
5. Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies.
Femiano F
Minerva Stomatol; 2002 Sep; 51(9):405-9. PubMed ID: 12473978
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study.
López-Jornet P; Camacho-Alonso F; Leon-Espinosa S
J Oral Rehabil; 2009 Jan; 36(1):52-7. PubMed ID: 18976257
[TBL] [Abstract][Full Text] [Related]
7. The Efficacy of Low-Level Laser Therapy in Burning Mouth Syndrome - A Pilot Study.
Sikora M; Včev A; Siber S; Vučićević Boras V; Rotim Ž; Matijević M
Acta Clin Croat; 2018 Jun; 57(2):312-315. PubMed ID: 30431725
[TBL] [Abstract][Full Text] [Related]
8. Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology.
Femiano F; Gombos F; Scully C; Busciolano M; De Luca P
Oral Dis; 2000 Sep; 6(5):274-7. PubMed ID: 11002408
[TBL] [Abstract][Full Text] [Related]
9. Burning mouth syndrome: the efficacy of lipoic acid on subgroups.
Femiano F; Gombos F; Scully C
J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):676-8. PubMed ID: 15482293
[TBL] [Abstract][Full Text] [Related]
10. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study.
Carbone M; Pentenero M; Carrozzo M; Ippolito A; Gandolfo S
Eur J Pain; 2009 May; 13(5):492-6. PubMed ID: 18675569
[TBL] [Abstract][Full Text] [Related]
11. Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial.
Palacios-Sánchez B; Moreno-López LA; Cerero-Lapiedra R; Llamas-Martínez S; Esparza-Gómez G
Med Oral Patol Oral Cir Bucal; 2015 Jul; 20(4):e435-40. PubMed ID: 26034927
[TBL] [Abstract][Full Text] [Related]
12. Effects of low-level laser therapy on burning mouth syndrome.
Valenzuela S; Lopez-Jornet P
J Oral Rehabil; 2017 Feb; 44(2):125-132. PubMed ID: 27893167
[TBL] [Abstract][Full Text] [Related]
13. Burning mouth syndrome: a systematic review of treatments.
Liu YF; Kim Y; Yoo T; Han P; Inman JC
Oral Dis; 2018 Apr; 24(3):325-334. PubMed ID: 28247977
[TBL] [Abstract][Full Text] [Related]
14. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial.
López-D'alessandro E; Escovich L
Med Oral Patol Oral Cir Bucal; 2011 Aug; 16(5):e635-40. PubMed ID: 20711135
[TBL] [Abstract][Full Text] [Related]
15. Effects of low-level laser therapy on burning pain and quality of life in patients with burning mouth syndrome: a systematic review and meta-analysis.
Lu C; Yang C; Li X; Du G; Zhou X; Luo W; Du Q; Tang G
BMC Oral Health; 2023 Oct; 23(1):734. PubMed ID: 37814265
[TBL] [Abstract][Full Text] [Related]
16. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol.
Femiano F; Lanza A; Buonaiuto C; Gombos F; Nunziata M; Cuccurullo L; Cirillo N
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e22-7. PubMed ID: 18155597
[TBL] [Abstract][Full Text] [Related]
17. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy.
Femiano F; Scully C
J Oral Pathol Med; 2002 May; 31(5):267-9. PubMed ID: 12110042
[TBL] [Abstract][Full Text] [Related]
18. Effect of low-level laser therapy in the treatment of burning mouth syndrome: a case series.
dos Santos Lde F; Carvalho Ade A; Leão JC; Cruz Perez DE; Castro JF
Photomed Laser Surg; 2011 Dec; 29(12):793-6. PubMed ID: 22150094
[TBL] [Abstract][Full Text] [Related]
19. Low-level laser therapy in burning mouth syndrome patients: a pilot study.
Kato IT; Pellegrini VD; Prates RA; Ribeiro MS; Wetter NU; Sugaya NN
Photomed Laser Surg; 2010 Dec; 28(6):835-9. PubMed ID: 21142725
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and non-pharmacological management of burning mouth syndrome: A systematic review.
Reyad AA; Mishriky R; Girgis E
Dent Med Probl; 2020; 57(3):295-304. PubMed ID: 33113291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
